Free Trial

Cabaletta Bio (CABA) SEC Filings & 10K Form

Cabaletta Bio logo
$1.71 +0.06 (+3.64%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$1.70 -0.01 (-0.58%)
As of 08/15/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cabaletta Bio SEC Filings

DateFilerForm TypeView
08/14/2025
4:29 PM
Alyeska Investment Group, L.P. (Filed by)
Cabaletta Bio (Subject)
Form SCHEDULE 13G
08/14/2025
2:02 PM
Cabaletta Bio (Subject)
Cormorant Asset Management, LP (Filed by)
Form SCHEDULE 13G
08/12/2025
8:04 AM
Adage Capital Management, L.P. (Filed by)
Cabaletta Bio (Subject)
Form SCHEDULE 13G/A
08/11/2025
3:27 PM
Cabaletta Bio (Subject)
Nichtberger Steven (Filed by)
Form SCHEDULE 13G/A
08/07/2025
7:26 AM
Cabaletta Bio (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/07/2025
6:41 AM
Cabaletta Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2025
6:37 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2025
1:19 PM
Cabaletta Bio (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G/A
07/29/2025
10:23 AM
Cabaletta Bio (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
07/16/2025
6:02 PM
BlackRock, Inc. (Filed by)
Cabaletta Bio (Subject)
Form SCHEDULE 13G/A
06/20/2025
4:22 PM
Cabaletta Bio (Subject)
CITADEL ADVISORS LLC (Filed by)
Form SCHEDULE 13G
06/12/2025
5:03 AM
Cabaletta Bio (Filer)
Form 424B5
06/12/2025
5:05 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
5:36 AM
Cabaletta Bio (Filer)
Form 424B5
06/11/2025
5:11 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
7:22 PM
Brun Scott C. (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
7:28 PM
Cabaletta Bio (Issuer)
Simon Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
7:16 PM
Cabaletta Bio (Issuer)
HENRIQUES RICHARD C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
7:17 PM
Cabaletta Bio (Issuer)
Tomasello Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
7:20 PM
Bollard Catherine (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:38 PM
Cabaletta Bio (Issuer)
Tomasello Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:39 PM
Cabaletta Bio (Issuer)
HENRIQUES RICHARD C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:39 PM
Cabaletta Bio (Issuer)
Gerard Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:40 PM
Cabaletta Bio (Issuer)
Nichtberger Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:44 PM
Brun Scott C. (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:33 PM
Cabaletta Bio (Issuer)
Chang David J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:34 PM
Bollard Catherine (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:34 PM
Cabaletta Bio (Issuer)
Das Arun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:36 PM
Binder Gwendolyn (Reporting)
Cabaletta Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:36 PM
Cabaletta Bio (Issuer)
Simon Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
8:36 PM
Cabaletta Bio (Issuer)
Marda Anup (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:22 PM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
6:05 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
6:10 AM
Cabaletta Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
7:00 AM
Cabaletta Bio (Filer)
Form DEF 14A
05/13/2025
7:02 AM
Cabaletta Bio (Filer)
Form ARS
04/30/2025
7:00 AM
Cabaletta Bio (Filer)
Form PRE 14A
03/31/2025
11:15 PM
Cabaletta Bio (Filer)
Form EFFECT
03/31/2025
7:33 AM
Cabaletta Bio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/31/2025
7:22 AM
Cabaletta Bio (Filer)
Form POS AM
03/31/2025
6:16 AM
Cabaletta Bio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
New law could create $3.7 trillion tsunami. (Ad)

During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.

03/31/2025
6:03 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
6:11 AM
Cabaletta Bio (Filer)
Form POSASR
03/04/2025
3:48 PM
Cabaletta Bio (Issuer)
Chang David J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:48 PM
Cabaletta Bio (Issuer)
Das Arun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:49 PM
Cabaletta Bio (Issuer)
Gerard Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:45 PM
Cabaletta Bio (Issuer)
Nichtberger Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
12:03 PM
Cabaletta Bio (Filer)
Form 8-K/A
02/18/2025
6:05 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:10 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:50 PM
Cabaletta Bio (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
12/05/2024
2:36 PM
Cabaletta Bio (Subject)
JENNISON ASSOCIATES LLC (Filed by)
Form SC 13G/A
11/18/2024
6:05 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:46 PM
Cabaletta Bio (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
3:02 PM
ALGER ASSOCIATES INC (Filed by)
Cabaletta Bio (Subject)
Form SC 13G/A
11/14/2024
6:07 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:14 AM
Cabaletta Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
8:34 AM
Adage Capital Management, L.P. (Filed by)
Cabaletta Bio (Subject)
Form SC 13G/A
11/04/2024
11:01 AM
Cabaletta Bio (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:38 AM
Cabaletta Bio (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:38 AM
Cabaletta Bio (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/17/2024
11:00 AM
Cabaletta Bio (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/07/2024
5:06 AM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:30 PM
Cabaletta Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
5:10 PM
Bain Capital Life Sciences Opportunities III, LP (Filed by)
Cabaletta Bio (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CABA) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners